Meral K. El Ramahi, MD MeralElRamahiMD
5 years 3 months ago
⭐️JUNIPERA: RCT of SEC in active ERA & JPsA (2-18yo, most on MTX)
-Tx . (TP)1: SEC 75/100 mg till wk 12
-TP2: cont SEC or switch to PBO till wk 104
⭐️SEC efficacious on JIA ACR30/70
⭐️74% w/ resolution of enthes
⭐️Median T2flare in PBO in TP2 = 453d
LB0004 #EULAR2021 @Rheumnow https://t.co/JsG2pXz9r6
Meral K. El Ramahi, MD MeralElRamahiMD
5 years 3 months ago
What to tell pts about diet?
*⃣Nutrition plays a role in inflammation in RMD & co-morbidities. What you eat matters!
*⃣ LImit salt, replace w/ herbs
*⃣ Consume low glycemic index foods.
Soda ⬆️risk of RA in women
*⃣⬆️omega-3 ⬇️omega-6 (dairy, eggs)
#EULAR2021 @Rheumnow
Eric Dein ejdein1
5 years 3 months ago
#EULAR2021 POS0236
Comparison of work productivity b/w CBP w & w/o AxSpA - 2 years from SPACE cohort
⭐️AxSpA showed significant ⬇️ in work productivity loss (WPL) compared to CBP wo AxSpA
Can use to counsel AxSpA patients that we have effective Rx for return to work
@RheumNow
Eric Dein ejdein1
5 years 3 months ago
#EULAR2021 POS0237: Gut dysbiosis linked to worse disease status in axSpA.
⭐️Dysbiosis in 33% of AxSpA vs 17% of controls wo rheumatic disease
⭐️Gut dysbiosis associated with worsening disease activity
@RheumNow https://t.co/rRl4Zbs7xc
Dr. John Cush RheumNow
5 years 3 months ago
BUT.....the SEC results were significant if you only looked at those with moderate to severe rotator cuff tendinopathy? Curious study, I think worthy of a well designed prospective trial. https://t.co/kqGink3sjU
Robert B Chao, MD doctorRBC
5 years 3 months ago
Baseline Vitamin D 😎☀️correlated with biologic response in RA pts.
⭐️EULAR good response: 19.6% Vit D >20 vs 4.2%⬇️Vit D
⭐️Remission: 14.4% ⬆️Vit D vs 3.2% ⬇️Vit D
Abs#POS0100
#EULAR2021 @RheumNow
Robert B Chao, MD doctorRBC
5 years 3 months ago
Time to go raspberry picking?
Rubus idaeus leaf extract 400mg and 200mg after 12 weeks
⬇️ VAS pain in knee OA compared to placebo
⭐️no effect on WOMAC, SF-36, 20m walking
Abs#POS0281
#EULAR2021 @RheumNow https://t.co/QAiag2XjRh
Robert B Chao, MD doctorRBC
5 years 3 months ago
Fellow rheumatologists, make sure to take care of yourself!
Latin America study
⭐️57% rheumatologists experienced burnout
⭐️associated with ⬇️age, ⬆️hours, ⬇️satisfaction, ⬇️happiness, ⬆️suicidal thoughts, income
Abs#POS0302
#EULAR2021 @RheumNow
Robert B Chao, MD doctorRBC
5 years 3 months ago
MSK US before 1st clinic visit?
Abs#POS0260 showed ⬇️ in time to diagnosis of inflammatory arthritis from 31 to 12 days and ⬇️clinical visits 2.8 to 2.1
How do you use MSK US in your clinic?
#EULAR2021 @RheumNow
Robert B Chao, MD doctorRBC
5 years 3 months ago
Mavrilimumab (GM-CSFi) phase II trial of COVID-19 PNA and systemic hyperinflammation
⭐️65% risk reduction in ventilation/death
⭐️no sig difference in ventilation requirement
⭐️no serious AE
Abs#LB0001
#EULAR2021 @RheumNow
Robert B Chao, MD doctorRBC
5 years 3 months ago
Excellent talk on SLE, APS abs pregancy
⭐️pregnancy counseling is important
⭐️aspirin 81mg in all pregnant SLE pts
⭐️do not discontinue HCQ
⭐️stable LN - can switch MMF to AZA
Abs#6888
#EULAR2021 @RheumNow
Md Yuzaiful Md Yusof Yuz6Yusof
5 years 3 months ago
Close call between LLDAS and DORIS Remission as a treat-to-target in #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/r3OnSrmQkH
Md Yuzaiful Md Yusof Yuz6Yusof
5 years 3 months ago
Results are out. The majority would use #anifrolumab to treat refractory skin and joints disease #SLE. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/wguBCkhZ7B
Md Yuzaiful Md Yusof Yuz6Yusof
5 years 3 months ago
No clear winner here. The majority would use #IL23 inhibitors as either 2nd or 3rd line bDMARDs and for #psoriaticarthritis with severe #psoriasis. Thank you for participating in the polls #EULAR2021 @RheumNow https://t.co/b8wzaRVTqw
David Liew drdavidliew
5 years 3 months ago
This is by far the biggest rheum dx COVID vaccinated cohort described I'm aware of 👏
Looking forward to full paper, & we will need data with more pts, more details, cellular response etc.
Nevertheless, invaluable & reassuring.
So glad to see it at #EULAR2021 LB0003 @RheumNow https://t.co/jsHZjLdCTT

